NCT05292859
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenosquamous Cell Lung Cancer, +45 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Adenocarcinoma of Lung
Explore clinical trials studying Adenocarcinoma of Lung. Study availability and eligibility vary by location and protocol.
266 public trials
48 recruiting studies
Adenocarcinoma of Lung trial results
NCT06477211
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +10 more
- Locations
-
- Nanjing Drum Tower hospital Nanjing, Jiangsu, China
NCT03845296
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +23 more
- Locations
-
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
NCT06953492
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +15 more
- Locations
-
- Zhong Shan hospital Shanghai, China
NCT03054298
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenoma, +35 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT03676192
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +7 more
- Locations
-
- Chung-Ang University Hospital Seoul, South Korea
NCT01828112
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
- Locations
-
- Highlands Oncology Group Fayetteville, Arkansas, United States
- Memorial Cancer Institute Hollywood, Florida, United States
- Cancer Specialists of North Florida Jacksonville, Florida, United States
- University Of Miami Miami, Florida, United States
NCT04588064
- Conditions
- 18F-FDG, 68Ga-FAPI, Adenocarcinoma, +11 more
- Locations
-
- The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
NCT01828099
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
- Locations
-
- Novartis Investigative Site CABA, Buenos Aires, Argentina
- Novartis Investigative Site CABA, Buenos Aires, Argentina
- Novartis Investigative Site La Rioja, Argentina
- Novartis Investigative Site Woolloongabba, Queensland, Australia
Completed
Lung Cancer Mutation Consortium Protocol
NCT01014286
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of Lung, Stage IV, +8 more
- Locations
-
- University of Colorado Denver Cancer Center Aurora, Colorado, United States